Company: GCTS
Filing Date: 2025-05-13
Form Type: S-3/A
Source: 0001104659-25-047808
Chunk: 3

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-05-13
Form: S-3/A
Chunk 3
---
 (the “Affiliated Stockholder”) originally issued in a private placement in connection with the initial public offering
of Concord Acquisition Corp III (“Concord III”) by the holders thereof and allocated to Affiliated Stockholder upon the consummation
of the business combination, (b) up to 17,250,000 shares of Common Stock that are issuable upon the exercise of 17,250,000 warrants
(the “Public Warrants”) originally issued in the initial public offering of Concord III by the holders thereof, (c) up
to 2,295,333 shares of Common Stock that are issuable upon the exercise of 2,295,333 warrants held by certain warrants holders of GCT
Semiconductor, Inc. (the “GCT Warrants”) and (d) up to 148,320 shares of Common Stock that are issuable upon the
exercise of 148,320 warrants held by Anapass, Inc. pursuant to a securities purchase agreement (the “Anapass Securities Purchase
Agreement”) entered into on September 26, 2024 (the “Anapass Warrants” and together with the GCT Warrants, Public
Warrants and Private Placement Warrants, the “Warrants”).

This prospectus also relates
to the offer and sale from time to time by the selling securityholders named in this prospectus (the “Selling Securityholders”)
of (i) up to 36,261,987 shares of Common Stock consisting of (a) up to 6,580,000 shares of Common Stock issuable upon exercise
of the Private Placement Warrants at a price of $11.50 per share, which were initially issued to Sponsors at an effective purchase price
of $1.00, (b) 19,685,138 shares of Common Stock acquired by certain Selling Securityholders party to the Registration Rights Agreement
(as defined herein), at an effective purchase price ranging from $0.00 to $120.48 per share, (c) up to 4,529,967 shares of Common
Stock originally issued to investors in a private placement pursuant to those certain Subscription Agreements (the “PIPE Shares”)
at an effective purchase price of $6.67 per share, (d) up to 1,781,626 shares of Common Stock issued to certain third parties as
consideration for their entry into certain non-redemption agreements with Concord III and the Sponsor (the “NRA Investors”)